The ROI on pant-wearing and other social media tips
By Dr. Matthew Watson
For other things, however, the people around you have such high expectations you'll do them that you only lose points if you don't but gain very little if you do. For you, this may be true of the dishes. Certainly I've always maintained this is true for Valentine's Day. Get flowers and you simply maintain the relationship's status quo; fail to do anything and you lose big points fast.
"I can tell you without the slightest hesitation of conviction – having experienced it myself and seen it repeated countless times – is that active and successful social media engagement translates into:
- Unparalleled learning: accessing more information relevant to your discipline, specialty and company than you otherwise will.
- Enhanced profile: higher profile within your industry, profession, specialty and community. Social media is not the only way to build a profile but it can be very effective.
- Wider network: more touch points and meaningful relationships with people than you otherwise will accomplish by any other means combined."
- Traffic: "For companies, increased traffic equals increased opportunity to call readers/viewers to your intended action – interaction, citation, linking, investing, buying or engaging in some other action you solicit. For individual professionals, increased viewers translate into more chances for collaboration, citation, engagement, etc."
- Collaboration: "There is an intrinsic correlation between one’s profile and the opportunities one has for collaboration. For companies this means finding the right partnerships, joint ventures, strategic alliances, collaborators, employees, management and so on. For individual professionals, this means more and/or better quality invites to speak, write or collaborate in other ways. It also means finding quality grad students, faculty, employees and interns
- Revenue/Income: This is about translating a broader knowledge base and a wider network over which you have some level of influence (if only just that they are listening) into more money for your company, organization and yourself. For companies, this means finding the right partners, investors, customers and so on. For organizations this means finding the right donors, impressing the right grant reviewers and/or recruiting the right rain-maker faculty. For individual professionals this translates into promotions or job offers."
As I conclude my article I will conclude here:
"In order to create the kinds of perceptions and solicit the kinds of actions we want from the world around us, we must engage the world around us. The world around us is engaging online.
For all kinds of selfish and selfless reasons you, your company or organization and your career will benefit from you engaging there too."
and this prediction:
"...in less than the blink it took for the commercial world to accept websites and email, it will seem similarly ridiculous for professionals, academics and companies to operate and succeed without actively using social media."
____________
If this topic is of interest to you, here are some great resources particularly focused on the value of social media to those in life sciences.
Canaday, M. Is Life Science Social Media Worth It Yet? Three Tenets Behind Its Relevance To Your Business. Comprendia. 6 December 2012.
Bersenev A. Scientific blogging as a model for professional networking online. Cellular Therapy and Transplantation. 2010;2(7). 10.3205/ctt-2010-en-000084.01.
Bersenev, A. Scientific blogging as a model for professional networking online. 4 August 2010. StemCellAssays.com
Bersenev, A. Who’s Who in the Stem Cell Blogosophere. 27 June 2011. StemCellAssays.com
Bishop, D. How to bury your academic writing. Bishop’s Blog. 26 August 2012.
Buckler, L. If You’re Breathing, You’re in PR. Cell Therapy Blog. 11 June 2010.
Buckler, L. Don’t feel the pain of ignoring social media? Just wait a minute…. CellTherapyBlog.com 22 October 2008.
Jewell, T. Survey: How our scientists use social media. AZHealthConnections.com. 12 February 2012.
Knoepfer, P. Top ten tips for blogging for scientists. 2 August 2012. IPScell.com
Shipman, M. Why Scientists Should Publicize Their Findings – for Purely Selfish Reasons. Scientific America. Blog. 18 June 2012.
Shipman, M. A gentle introduction to Twitter for the apprehensive academic. Scientific America. Blog. 14 June 2011.
Small, G. Time to Tweet. Nature 2011. 479 141 2 November 2011
Wilcox, C. Social Media for Scientists Part 1: It’s Our Job. Scientific American Blog. 27 September 2011.
Wilcox, C. Social Media for Scientists Part 2: You Do Have time. Scientific American Blog. 29 September 2011.
Wilcox, C. Social Media for Scientists Part 3: Win-Win. Scientific American Blog. 10 October 2011.
Wilcox, C. Guest Editorial: It’s time to e-Volve. Taking Responsibility for Science Communication in a Digital Age. Biol Bull. 22285-87. (April 2012)
The Rules of Social Media. Fast Company. 8 August 2012.
Source:
http://feedproxy.google.com/~r/CellTherapyBlog/~3/k7ANTnLXNjc/the-roi-on-pant-wearing-and-other.html
- Commercialization of Regenerative Medicine: Learning from Spin-Outs - April 28th, 2013
- 2013 Annual Regenerative Medicine Industry Report - April 21st, 2013
- Cell Therapy Blog welcomes 2013 - January 6th, 2013
- The Accuracy of Adipose Stem Cell Doses - December 23rd, 2012
- A proposed 6-step platform for the cell therapy industry to consider in combating non-compliant cell therapy treatments - December 16th, 2012
- Six steps to fighting non-compliant cell therapy treatments. --- The stuff of grey shades, spades, ivory towers and (ahem) balls. - December 2nd, 2012
- Cell Therapy Industry Group Welcomes its 4,000th member - November 11th, 2012
- GEN's "Cellular Therapy Wave Finally Cresting". An overview and data set. - November 4th, 2012
- CIRM addresses some tough questions. Is it all just glass towers and basic research? - October 21st, 2012
- Cell therapy portfolio outperforms major indices year-to-date - October 14th, 2012
- The cost of clinical trial data bias/loss, FDA's new job and the need for bold leadership. - September 30th, 2012
- Anticipated short-term cell therapy industry clinical milestones - September 30th, 2012
- Two lessons I learned this week. - September 16th, 2012
- Are some cell counts too good to be true? Why some companies' product data may mislead. - September 2nd, 2012
- Is the cell therapy sector outperforming the major indices? - August 12th, 2012
- FDA 1. RSI 0. Regenerative Sciences (Regenexx) vs FDA (2012) - July 29th, 2012
- Bioreactor Design and Bioprocess Controls for Industrialized Cell Processing - June 17th, 2012
- Industry-sponsored cardiovascular cell therapies. Some metrics. - May 27th, 2012
- Cell-based Cancer Immunotherapies. Some metrics.. - May 20th, 2012
- Another > $100M month for companies in the cell therapy space - May 6th, 2012
- Predicting the Success of the Late-Stage Cell-Based Cancer Immunotherapy Pipeline? - March 11th, 2012
- 2011 EMA Committee for Advanced Therapies (CAT) classification record. What can be learned? - January 1st, 2012
- Inactive and recently failed or terminated phase III or II/III cell therapy trials - December 18th, 2011
- Recently approved cell therapy products - December 18th, 2011
- Active phase III or II/III cell therapy trials - December 11th, 2011
- Sabrina Cohen Foundation Thanks Stem Cell Researchers - November 27th, 2011
- Commercializing Cell-based Regenerative Medicines - November 13th, 2011
- Cell Therapy & Regenerative Medicine Domains Available - September 25th, 2011
- Commercial-stage Cell Therapy Companies and Products - September 18th, 2011
- Potential far-reaching implications of the ongoing fight over point-of-care autologous cell therapy - September 18th, 2011
- Good Data? $100. Good Product Development? $100. Good Commercialization Strategy? Priceless. - August 14th, 2011
- Clinical trial costs - July 31st, 2011
- Cell Therapy's Got Talent Technology Showcase - A Call for Cell Therapy Manufacturing Technology Presentations - July 10th, 2011
- In vivo cell trafficking just took a leap forward - July 3rd, 2011
- Cell Therapies: Commercializing a New Class of Biopharmaceuticals - February 12th, 2011
- The LinkedIn Cell Therapy Industry Group - 1,000 members strong - January 15th, 2011
- Careers in cell therapy & regenerative medicine - October 11th, 2010
- FDA files injunction again Regenerative Sciences citing Regenexx violates regulations - August 12th, 2010
- The changing face of PR and why it matters to regenmed - June 12th, 2010
- Biotech tax credit appears perfectly designed for cell therapy companies to recoup research dollars spent in 2009-10 - May 22nd, 2010
- Google to Invest in Regenerative Medicine - May 5th, 2010
- Latest Cell Therapy Approval by FDA. Dendreon's Provenge. - April 30th, 2010
- Stem cells for a Webby! - April 28th, 2010